MU Investments Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.88M | Sell |
58,470
-500
| -0.8% | -$17.7K | 2.51% | 22 |
|
|
2023
Q2 | $2.13M | Sell |
58,970
-400
| -0.7% | -$15.6K | 2.7% | 23 |
|
|
2023
Q1 | $2.4M | Sell |
59,370
-3,000
| -5% | -$130K | 3.15% | 24 |
|
|
2022
Q4 | $3.2M | Sell |
62,370
-160
| -0.3% | -$7.67K | 4.11% | 19 |
|
|
2022
Q3 | $2.76M | Hold |
62,530
| – | – | 3.83% | 16 |
|
|
2022
Q2 | $3.19M | Sell |
62,530
-3,420
| -5% | -$174K | 4.31% | 8 |
|
|
2022
Q1 | $3.46M | Hold |
65,950
| – | – | 3.78% | 16 |
|
|
2021
Q4 | $3.8M | Buy |
+65,950
| New | +$3.27M | 3.83% | 24 |
|
|
2018
Q4 | – | Sell |
-159,576
| Closed | -$6.62M | – | 30 |
|
|
2018
Q3 | $6.65M | Hold |
159,576
| – | – | 4.2% | 9 |
|
|
2018
Q2 | $5.5M | Hold |
159,576
| – | – | 3.85% | 16 |
|
|
2018
Q1 | $5.37M | Sell |
159,576
-1,654
| -1% | -$56.9K | 3.83% | 16 |
|
|
2017
Q4 | $5.56M | Buy |
161,230
+158,943
| +6,950% | +$5.42M | 3.81% | 19 |
|
|
2017
Q3 | $77K | Sell |
2,287
-633
| -22% | -$20.3K | 0.06% | 38 |
|
|
2017
Q2 | $93K | Sell |
2,920
-1,212
| -29% | -$38.2K | 0.07% | 40 |
|
|
2017
Q1 | $135K | Sell |
4,132
-379
| -8% | -$11.9K | 0.1% | 38 |
|
|
2016
Q4 | $139K | Sell |
4,511
-1,792
| -28% | -$54.7K | 0.1% | 39 |
|
|
2016
Q3 | $199K | Sell |
6,303
-6,324
| -50% | -$211K | 0.15% | 36 |
|
|
2016
Q2 | $419K | Sell |
12,627
-9,802
| -44% | -$313K | 0.28% | 33 |
|
|
2016
Q1 | $640K | Sell |
22,429
-211
| -0.9% | -$6.03K | 0.4% | 36 |
|
|
2015
Q4 | $696K | Sell |
22,640
-19,583
| -46% | -$616K | 0.41% | 37 |
|
|
2015
Q3 | $1.24M | Sell |
42,223
-7,800
| -16% | -$250K | 0.67% | 30 |
|
|
2015
Q2 | $1.59M | Sell |
50,023
-3,583
| -7% | -$117K | 0.76% | 28 |
|
|
2015
Q1 | $1.78M | Sell |
53,606
-4,259
| -7% | -$135K | 0.83% | 28 |
|
|
2014
Q4 | $1.74M | Sell |
57,865
-210
| -0.4% | -$6.02K | 0.75% | 29 |
|
|
2014
Q3 | $1.64M | Sell |
58,075
-6,725
| -10% | -$189K | 0.81% | 25 |
|
|
2014
Q2 | $1.82M | Buy |
64,800
+6,851
| +12% | +$195K | 0.84% | 26 |
|
|
2014
Q1 | $1.75M | Sell |
57,949
-8,780
| -13% | -$262K | 0.81% | 28 |
|
|
2013
Q4 | $1.93M | Buy |
66,729
+1,085
| +2% | +$31.6K | 0.83% | 27 |
|
|
2013
Q3 | $1.8M | Sell |
65,644
-20,342
| -24% | -$553K | 0.86% | 26 |
|
|
2013
Q2 | $2.3M | Buy |
+85,986
| New | +$2.38M | 0.97% | 26 |
|
Other funds holding PFE
MU Investments Company's PFE Position: Q3 2023 in Review
MU Investments Company reduced its Pfizer (PFE) stake by 0.85% in Q3 2023, selling an estimated $17.7K and leaving 58,470 shares worth $1.88M. The position accounts for 2.51% of the portfolio, ranked #22.
MU Investments Company first reported a position in PFE in Q2 2013 and has held it in 30 quarters since. The position peaked at $6.65M in Q3 2018. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- MU Investments Company held 58,470 shares of Pfizer worth $1.88M as of Q3 2023.
- MU Investments Company sold 500 Pfizer shares in Q3 2023, an estimated $17.7K.
- Pfizer made up 2.51% of MU Investments Company's portfolio in Q3 2023, its #22 holding.
- MU Investments Company first reported a position in Pfizer in Q2 2013 and has held it in 30 quarters since.
- MU Investments Company's Pfizer position peaked at $6.65M in Q3 2018.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on MU Investments Company's 13F filing for Q3 2023, filed 7 Nov 2023.